NCT06134323View on ClinicalTrials.gov

Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder

NARecruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

August 30, 2025

Study Completion Date

September 30, 2025

Conditions
Generalized Anxiety Disorder
Interventions
DEVICE

medication-combined transcutaneous vagus nerve stimulation

Two electrodes will be applied 2 cm below the left carotid sinus for active stimulation

DEVICE

medication-combined sham stimulation

Two electrodes will be applied 2 cm below the left carotid sinus for sham stimulation

Trial Locations (2)

Unknown

RECRUITING

The First Affiliated Hospital of Air Force Military Medical University, Xi'an

RECRUITING

Xi'an No.3 Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER